NCT07003464 2025-06-04
Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study
The First Hospital of Jilin University
Phase 2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × Bendamustine Hydrochloride × Clear all